Dave Neal, President and Founder of STAT Design11.21.19
Molybdenum-Rhenium is a new biomaterial to the orthopedic market that is exciting because of its biocompatibility, MRI and CT compatibility, and corrosion resistance. Its combination of high tensile strength and ductility allows implanted devices to be designed with a low profile. It has excellent osteo-integration properties and very low levels of ion release.
Molybdenum-Rhenium offers superior mechanical strength properties over other approved biomaterials, such as cobalt-chrome, titanium, and stainless steel. It also uses a lot less metal to achieve the same strength and durability and is two to three times stronger and four times more durable than cobalt-chrome or titanium.
By offering superior mechanical strength properties, these implantable medical devices can be made thinner, providing a low profile. Additionally, devices made from this material, can benefit from being implanted minimally invasively which may lead to improved clinical outcomes, by reducing soft tissue disruption.
History
Rhenium was discovered in 1925 and is the last stable non-radioactive inert element discovered. Molybdenum-Rh
Molybdenum-Rhenium offers superior mechanical strength properties over other approved biomaterials, such as cobalt-chrome, titanium, and stainless steel. It also uses a lot less metal to achieve the same strength and durability and is two to three times stronger and four times more durable than cobalt-chrome or titanium.
By offering superior mechanical strength properties, these implantable medical devices can be made thinner, providing a low profile. Additionally, devices made from this material, can benefit from being implanted minimally invasively which may lead to improved clinical outcomes, by reducing soft tissue disruption.
History
Rhenium was discovered in 1925 and is the last stable non-radioactive inert element discovered. Molybdenum-Rh
Continue reading this story and get 24/7 access to Orthopedic Design Technology for FREE
FREE SUBSCRIPTION
